UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 24, 2016 (August 22, 2016)
VIVEVE MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware | | 1-11388 | | 04-3153858 |
(State or other jurisdiction
of incorporation) | | (Commission File Number) | | (I.R.S. Employer
Identification No.) |
150 Commercial Street Sunnyvale, California | | 94086 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (408) 530-1900
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07. Submission of Matters to a Vote of Security Holders.
On August 22, 2016, Viveve Medical, Inc. (the “Company”) held its 2016 Annual Meeting of Stockholders (the “Meeting”). At the Meeting, the Company’s stockholders voted to: (1) elect seven directors to the Company’s board of directors (the “Board”); (2) approve the Viveve Medical, Inc. Amended and Restated 2013 Stock Option and Incentive Plan (the “Plan”); (3) ratify the appointment of Burr Pilger Mayer, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016; and (4) approve the compensation of the named executive officers in a non-binding advisory vote.
The proposals were approved based on the voting results as follows:
Proposal 1: Elect Seven Directors to the Board.
Director | | Votes For | | | Votes Withheld | | | Broker Non-Votes | |
Lori Bush | | 8,159,834 | | | 1,159 | | | 1,253,457 | |
Daniel Janney | | 8,159,893 | | | 1,100 | | | 1,253,457 | |
Debora Jorn | | 8,159,893 | | | 1,100 | | | 1,253,457 | |
Arlene Morris | | 8,159,836 | | | 1,157 | | | 1,253,457 | |
Jon Plexico | | 8,159,874 | | | 1,119 | | | 1,253,457 | |
Patricia Scheller | | 8,159,837 | | | 1,156 | | | 1,253,457 | |
Brigitte Smith | | 7,938,894 | | | 222,099 | | | 1,253,457 | |
Proposal 2: Approve the Plan.
Votes For | Votes Against | Abstentions | Broker Non-Votes |
7,747,470 | 411,766 | 1,757 | 1,253,457 |
Proposal 3: Ratify the appointment of Burr Pilger Mayer, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016.
Votes For | Votes Against | Abstentions |
9,399,644 | 1,896 | 12,910 |
Proposal 4: Approve the compensation of the Company’s named executive officers in a non-binding advisory vote.
Votes For | Votes Against | Abstentions | Broker Non-Votes |
8,151,903 | 6,931 | 2,159 | 1,253,457 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VIVEVE MEDICAL, INC. | |
| | |
| | | |
Date: August 24, 2016 | By: | /s/ Patricia Scheller | |
| | Name: Patricia Scheller Title: Chief Executive Officer | |
